ANAHEIM, Calif., April 24, 2014 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today announced that it will release first quarter 2014 financial results on Monday, April 28, 2014 after the close of the U.S. financial markets. In light of Questcor's pending merger with Mallinckrodt plc, the Company will not be hosting a conference call to discuss its financial results. Further details will be available in a Form 10-Q filing to be filed with the Securities and Exchange Commission after the earnings release.
Questcor Pharmaceuticals, Inc. is a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Questcor also provides specialty contract manufacturing services to the global pharmaceutical industry through its wholly-owned subsidiary BioVectra Inc. For more information about Questcor, please visit www.questcor.com
SOURCE Questcor Pharmaceuticals, Inc.